CD36, oxidized LDL and PPARγ: Pathological interactions in macrophages and atherosclerosis

Vascular Pharmacology

Volumn 41, Issue 4-5, 2004, Pages 139-146

  Nicholson, Andrew C ^a   Hajjar, David P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD36; Oxidized LDL; PPAR

Indexed keywords

2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL] ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2 [1 CARBOXY 2 [4 [2 (5 METHYL 2 PHENYL 4 OXAZOLYL)ETHOXY]PHENYL]ETHYLAMINO]BENZOIC ACID METHYL ESTER; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CD36 ANTIGEN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PITAVASTATIN; ROSIGLITAZONE; SCAVENGER RECEPTOR; TROGLITAZONE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ATHEROGENESIS; ATHEROSCLEROSIS; DIABETES MELLITUS; HUMAN; INSULIN RESISTANCE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

EID: 10444278021     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2004.08.003     Document Type: Article

References (54)

1. S. Acton, R. Attilio, K. Landschultz, S. Xu, H. Hobbs, and M. Krieger Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor Science 271 1996 518 520
2. M. Adams, J. Reginato, D. Shao, M. Lazar, and V.K. Chatterjee Transcriptional activation by peroxisome proliferator-activated receptor g is inhibited by phosphorylation at a consensus mitogen-activated kinase site J. Biol. Chem. 272 1997 5128 5132
3. T.J. Aitman, A.M. Glazier, CA. Wallace, L.D. Cooper, P.J. Norsworthy, F.N. Wahid, K.M. Al-Majali, P.M. Trembling, C.J. Mann, C.C. Shoulders, D. Graf, E. St Lezin, T.W. Kurtz, V. Kren, M. Pravenec, A. Ibrahimi, N.A. Abumrad, L.W. Stanton, and J. Scott Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats Nat. Genet. 21 1999 76 83
4. A. Boullier, K.L. Gillotte, S. Horkko, S.R. Green, P. Friedman, E.A. Dennis, J.L. Witztum, D. Steinberg, and O. Quehenberger The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein J. Biol. Chem. 275 2000 9163 9169
5. D. Calvo, and M.A. Vega Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family J. Biol. Chem. 268 1993 18929 18935
6. D. Calvo, D. Gomez-Coronado, Y. Suarez, M. Lasuncion, and M.A. Vega Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL J. Lipid Res. 39 1998 777 788
7. H.S. Camp, and S.R. Tafuri Regulation of peroxisome proliferator- activated receptor g activity by mitogen-activated protein kinase J. Biol. Chem. 272 1997 10811 10816
8. A. Chawla, Y. Barak, L. Nagy, D. Liao, P. Tontonoz, and R.M. Evans PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation Nat. Med. 7 2001 48 52
9. Z. Chen, S. Ishibashi, S. Perrey, J. Osuga, T. Gotoda, T. Kitamine, Y. Tamura, H. Okazaki, N. Yahagi, Y. Iizuka, F. Shionoiri, K. Ohashi, K. Harada, H. Shimano, R. Nagai, and N. Yamada Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL Arterioscler. Thromb. Vasc. Biol. 21 2001 372 377
10. G. Chinetti, S. Lestavel, V. Bocher, A.T. Remaley, B. Neve, I.P. Torra, E. Teissier, A. Minnich, M. Jaye, N. Duverger, H.B. Brewer, J.C. Fruchart, V. Clavey, and B. Staels PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat. Med. 7 2001 53 58
11. A.R. Collins, W.P. Meehan, U. Kintscher, S. Jackson, S. Wakino, G. Noh, W. Palinski, W.A. Hsueh, and R.E. Law Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice Arterioscler. Thromb. Vasc. Biol. 21 2001 365 371
12. M.A. Connelly, S. Klein, S. Azhar, N. Abumrad, and D.L. Williams Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake J. Biol. Chem. 274 1999 41 47
13. P.N. Durrington, B. Mackness, and M.I. Mackness Paraoxonase and atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 473 480
14. G. Endemann, L. Stanton, K. Madden, K. Bryant, R.T. White, and A. Protter CD36 is a receptor for oxidized low density lipoprotein J. Biol. Chem. 268 1993 11811 11816
15. M. Febbraio, N.A. Abumrad, D.P. Hajjar, K. Sharma, W. Cheng, S.F.A. Pearce, and R.L. Silverstein A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism J. Biol. Chem. 274 1999 19055 19062
16. M. Febbraio, E.A. Podrez, J.D. Smith, D.P. Hajjar, S.L. Hazen, H.F. Hoff, K. Sharma, and R.L. Silverstein Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice J. Clin. Invest. 105 2000 1049 1056
17. M. Febbraio, D.P. Hajjar, and R.L. Silverstein CD36: a class B scavenger receptor involved in angioigenesis, atherrosclerosis, inflammation, and lipid metabolism J. Clin. Invest. 108 2001 785 791
18. B. Fuhrman, L. Koren, N. Volkova, S. Keidar, T. Hayek, M. Aviram, T. Hayek, and M. Aviram Atorvastatin therapy in hypercholesterolomic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes Atherosclerosis 164 2002 179 185
19. T. Furuchi, and R.G.W. Anderson Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK) J. Biol. Chem. 273 1998 21099 21104
20. J. Han, D.P. Hajjar, M. Febbraio, and A.C. Nicholson Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36 J. Biol. Chem. 272 1997 21654 21659
21. J. Han, D.P. Hajjar, J.M. Tauras, and A.C. Nicholson Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36 J. Lipid Res. 40 1999 830 838
22. J. Han, D.P. Hajjar, J.M. Tauras, J. Feng, A.M. Gotto, and A.C. Nicholson Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma J. Biol. Chem. 275 2000 1241 1246
23. J. Han, D.P. Hajjar, X. Zhou, A.M. Gotto, and A.C. Nicholson Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein J. Biol. Chem. 277 2002 23582 23586
24. J. Han, X. Zhou, T. Yokoyama, D.P. Hajjar, A.M. Gotto, and A.C. Nicholson Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36 Circulation 17 2004 790 796
25. N. Hrboticky, G. Draude, G. Hapfelmeier, R. Lorenz, and P.C. Weber Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages Arterioscler. Thromb. Vasc. Biol. 19 1999 1267 1275
26. J.T. Huang, J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, C. Kelly, J.L. Witztum, C.D. Funk, D. Conrad, and C.K. Glass Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase Nature 400 1999 378 382
27. H.-Y. Huh, S.F.A. Pearce, L. Yesner, and R.L. Silverstein Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation Blood 87 1996 2020 2028
28. H. Kashiwagi, Y. Tomiyama, Y. Kosugi, M. Shiraga, R. Lipsky, Y. Kanayama, Y. Kurata, and Y. Matsuzawa Identification of the molecular defects in a subject with type I CD36 deficiency Blood 83 1994 3545 3552
29. Y.S. Li, Y.J. Shyy, J.G. Wright, A.J. Valente, J.F. Cornhill, and P.E. Kolattukudy The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo Mol. Cell. Biochem. 126 1993 61 68
30. A.C. Li, K.K. Brown, M.J. Silvestre, T.M. Willson, W. Palinski, and C.K. Glass Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice J. Clin. Invest. 106 2000 523 531
31. C.P. Liang, S. Han, H. Okamoto, R. Carnemolla, I. Tabas, D. Accili, and A.R. Tall Increased CD36 protein as a response to defective insulin signaling in macrophages J. Clin. Invest. 113 2004 764 773
32. K.H. Lin, K. Ashizawa, and S.Y. Cheng Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone nuclear receptor Proc. Natl. Acad. Sci. U. S. A. 89 1992 7737 7741
33. M. Lougheed, C. Lum, W. Ling, H. Suzuki, T. Kodama, and U. Steinbrecher High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II J. Biol. Chem. 272 1997 12938 12944
34. K.J. Moore, E.D. Rose, M.L. Fitzgerald, F. Randow, L.P. Andersson, D. Alshuler, D.S. Milstone, R.M. Mortensen, B.M. Spiegelman, and M.W. Freeman The role of PPAR-gamma in macrophage differentiation and cholesterol uptake Nat. Med. 7 2001 41 47
35. L. Nagy, P. Tontonoz, J. Alvarez, H. Chen, and R. Evans Oxidized LDL regulates macrophages gene expression through ligand activation of PPARg Cell 93 1998 229 240
36. T. Nakagawa, S. Nozaki, M. Nishida, J.M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, S. Yamashita, and Y. Matsuzawa Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages Arterioscler. Thromb. Vasc. Biol. 18 1998 1350 1357
37. A. Nakata, Y. Nakagawa, M. Nishida, S. Nozaki, J. Miyagawa, T. Nakagawa, R. Tamura, K. Matsumoto, K. Kameda-Takemura, S. Yamashita, and Y. Matsuzawa CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta Arterioscler. Thromb. Vasc. Biol. 19 1999 1333 1339
38. A. Nicholson, S.F.A. Pearce, and R. Silverstein Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site Arterioscler. Thromb. 15 1995 269 275
39. S. Nozaki, H. Kashiwagi, S. Yamashita, T. Nakagawa, B. Kostner, Y. Tomiyama, A. Nakata, M. Ishigami, J. Miyagawa, K. Kameda-Takemura, Y. Kurata, and Y. Matsuzawa Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects J. Clin. Invest. 96 1995 1859 1865
40. S. Parthasarathy, L. Fong, D. Otero, and D. Steinberg Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor Proc. Natl. Acad. Sci. U. S. A. 84 1987 537 540
41. A. Pietsch, W. Erl, and R.L. Lorenz Lovastatin reduces expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells Biochem. Pharmacol. 52 1996 433 439
42. E.A. Podrez, M. Febbraio, N. Sheibani, D. Schmitt, R.L. Silverstein, D.P. Hajjar, P.A. Cohen, W.A. Frazier, H.F. Hoff, and S.L. Hazen Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species J. Clin. Invest. 105 2000 1095 1108
43. E.A. Podrez, E. Poliakov, Z. Shen, R. Zhang, Y. Deng, M. Sun, P.J. Finton, L. Shan, B. Gugiu, P.L. Fox, H.F. Hoff, R.G. Salomon, and S.L. Hazen Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 277 2002 38503 38516
44. M. Pravenec, V. Landa, V. Zidek, A. Musilova, V. Kren, L. Kazdova, T.J. Aitman, A.M. Glazier, A. Ibrahimi, N.A. Abumrad, N. Qi, J.M. Wang, E.M. St Lezin, and T.W. Kurtz Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats Nat. Genet. 27 2001 156 158
45. M. Pravenec, V. Landa, V. Zidek, A. Musilova, L. Kazdova, N. Qi, J. Wang, E. St Lezin, and T.W. Kurtz Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension Physiol. Res. 52 2003 681 688
46. M. Ricote, A. Li, T. Wilson, C. Kelly, and C. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
47. A. Rigotti, S. Acton, and M. Krieger The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids J. Biol. Chem. 270 1995 16221 16224
48. H. Sakaguchi, M. Takeya, H. Suzuki, H. Hakamata, T. Kodama, S. Horiuchi, S. Gordon, L.J. van der Laan, G. Kraal, S. Ishibashi, N. Kitamura, and K. Takahashi Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice Lab. Invest. 78 1998 423 434
49. M.J. Sampson, I.R. Davies, S. Braschi, K. Ivory, and D.A. Hughes Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes Atherosclerosis 167 2003 129 134
50. P. Tontonoz, E. Hu, and B. Spiegelman Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma Curr. Opin. Genet. Dev. 5 1995 571 576
51. P. Tontonoz, L. Nagy, J. Alvarez, V. Thomazy, and R. Evans PPARg promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
52. N. Umetani, Y. Kanayama, M. Okamura, N. Negoro, and T. Takeda Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages Biochim. Biophys. Acta 1303 1996 199 206
53. J.C. Xue, E.J. Schwarz, A. Chawla, and M.A. Lazar Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma Mol. Cell. Biol. 16 1996 1567 1575
54. L. Yesner, H. Huh, S.F.A. Pearce, and R. Silverstein Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators Arterioscler. Thromb. 16 1996 1019 1025